Webinar Date/Time: Thu, Nov 7, 2024 11:00 AM EDT
Learn how the core analytical workflow of characterizing charge isoforms can be streamlined.
Register Free: https://www.biopharminternational.com/bp_w/advancing-core-workflows
Event Overview:
Characterization of charge isoforms, whether in early product development or associated with licensure filings, is usually achieved through separate analytical techniques. Fraction collection via ion-exchange (IEX) liquid chromatography or iCE followed by mass spectrometry are typically used.
This webinar discusses opportunities to advance core platform technologies through a fully integrated icIEF-UV/MS workflow on the Intabio ZT system and how rapid post-translational modification (PTM) characterization of charge isoforms can be used to guide decisions during early development.
Key Learning Objectives:
Who Should Attend:
Speakers:
Kristen Nields, PhD
Principal Scientist
Johnson & Johnson Innovative Medicine
Xiaoping He
Principal Scientist
Pfizer
Register Free: https://www.biopharminternational.com/bp_w/advancing-core-workflows
MHRA Approves GSK Therapy Combinations for Multiple Myeloma
April 21st 2025Belantamab mafodotin is approved in combination with bortezomib plus dexamethasone in patients who have had at least one prior therapy, and in combination with pomalidomide plus dexamethasone for those who have had a prior therapy including lenalidomide.
Tokyo University of Science Research Team Explores Improved Delivery of Antisense Oligonucleotides
April 18th 2025Using cholesterol-modified oligonucleotides, the research team aims to improve the delivery of antisense nucleotide-based therapies for treating neurodegenerative diseases and brain cancers.